Morphologic and molecular subtype status of individual tumor foci in multiple breast carcinoma. A study of 155 cases with analysis of 463 tumor foci

Human Pathology

Volumn 45, Issue 2, 2014, Pages 409-416

  Boros, Monica ^a   Ilyes, Agota ^a   Nechifor Boila, Adela ^a   Moldovan, Cosmin ^a   Eniu, Alexandru ^b   Stolnicu, Simona ^a  

^a UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b Cancer Institute Ion Chiricuta Cluj Napoca   (Romania)

Author keywords

Molecular status; Morphology; Multiple breast carcinoma

Indexed keywords

BIOLOGICAL MARKER; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; KI 67 ANTIGEN; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CANCER STAGING; CORRELATION ANALYSIS; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; MIDDLE AGED; MULTIPLE CANCER; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; VERY ELDERLY;

MOLECULAR STATUS; MORPHOLOGY; MULTIPLE BREAST CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES;

EID: 84892740427     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2013.10.006     Document Type: Article

References (29)

1. R. Yerushalmi, H. Kennecke, and R. Woods et al. Does multicentric/ multifocal breast cancer differ from unifocal breast cancer? An analysis of survival and contralateral breast cancer incidence Breast Cancer Res Treat 117 2009 365 370
2. A. Katz, E. Strom, and T. Buchholtz et al. The influence of pathologic tumor characteristics on loco regional recurrence rates following mastectomy Int J Paediatr Oncol Biol Phys 50 2001 735 742
3. S. Aebi, T. Davidson, G. Gruber, and F. Cardoso Primary breast cancer: ESMO clinical practice. Guidelines for diagnosis, treatment and follow-up Ann Oncol 22 Suppl. 6 2011 vi12 vi24
4. A. Goldhirsch, W.C. Wood, and A.S. Coates et al. Strategies for subtypes - dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 Ann Oncol 22 2011 1736 1747
5. R.W. Carlson, D.C. Allred, and B.O. Anderson et al. Invasive breast cancer: clinical practice guidelines in oncology J Natl Compr Canc Netw 9 2011 136 222
6. S. Lakhani, I.O. Ellis, S.J. Schnitt, P.H. Tan, and M.J. Van Vijver Tumours of the breast F.A. Tavassoli, P. Devilee, Tumours of the Breast and Female Genital Organs. WHO Classifications of Tumours 2012 IARC Press Lyon 13 77
7. S.B. Edge, D.R. Byrd, and C.C. Compton et al. Breast. In: American Joint Committee on Cancer (AJCC) cancer staging manual 7th ed 2010 Springer New York 347 376
8. L.H. Sobin, M.K. Gospodarowicz, and Ch. Wittekind International Union against Cancer (UICC): TNM classification of malignant tumors 7th ed. 2009 Wiley-Blackwell Oxford
9. S.C. Lester, S. Bose, and Y.Y. Chen et al. Protocol for the examination of specimens from patients with invasive carcinoma of the breast (College of American Pathologists) Arch Pathol Lab Med 133 2009 1515 1538
10. T. Tot, M. Gere, and G. Pekár et al. Breast cancer multifocality, disease extent, and survival Hum Pathol 42 2011 1761 1769
11. J. Boyages, U.W. Jayasinghe, and N. Coombs Multifocal breast cancer and survival: each focus does matter particularly for larger tumours Eur J Cancer 46 2010 1990 1996
12. I.O. Ellis, and C.W. Elston Histologic grade F.P. O'Malley, S.E. Pinder, Breast pathology 2006 Elsevier Philadelphia, PA 225 233
13. M. Boros, C. Marian, C. Moldovan, and S. Stolnicu Morphological heterogeneity of the simultaneous ipsilateral invasive tumor foci in breast carcinoma: a retrospective study of 418 cases of carcinomas Pathol Res Pract 208 2012 604 609
14. M.E. Hammond, D.F. Hayes, and M. Dowsett et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer J Clin Oncol 28 2010 2784 2795
15. A.C. Wolff, M.E. Hammond, and J.N. Schwartz et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer Arch Pathol Lab Med 131 2007 18 43
16. M.E. Hammond ASCO-CAP guidelines for breast predictive factor testing: an update Appl Immunohistochem Mol Morphol 19 2011 499 500
17. M. Dowsett, T.O. Nielsen, and R. A'Hern et al. Assessment of ki67 in breast cancer: recommendations from the International ki67 in Breast Cancer Working Group J Natl Cancer Inst 103 2011 1656 1664
18. P.J. Dawson, P.A. Baekey, and R.A. Clark Mechanisms of multifocal breast cancer: an immunocytochemical study Hum Pathol 26 1995 965 969
19. J.R. De la Haba-Rodriguez, M. Ruiz Borrego, and A. Gomez Espana et al. Comparative study of the immunohistochemical phenotype in breast cancer and its lymph node metastatic location Cancer Invest 22 2004 219 224
20. T. Tot The role of large-format histopathology in assessing subgross morphological prognostic parameters: a single institution report of 1000 consecutive breast cancer cases Int J Breast Cancer. 2012 2012 395 415 10.1155/2012/395415
21. P.L. Fitzgibbons, D.L. Page, and D. Weaver et al. Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999 Arch Pathol Lab Med 24 2000 966 978
22. Early Breast Cancer Trialists Collaborative Group Tamoxifen for early breast cancer: an overview of the randomised trials Lancet 351 1998 1451 1467
23. S. Paik, R. Hazan, and E.R. Fisher et al. Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer J Clin Oncol 8 1990 103 112
24. M. De Laurentiis, G. Arpino, and E. Massarelli et al. A metaanalysis on the interaction between HER-2 expression and response to endocrine treatment in advanced breast cancer Clin Cancer Res 11 2005 4741 4748
25. L. Middleton, G. Vlastos, N. Mirza, S. Eva, and A.A. Sahin Multicentric mammary carcinoma Cancer 94 2002 1910 1916
26. V. Garimella, E.D. Long, S.L. O'Kane, P.J. Drew, and L. Cawkwell Oestrogen and progesterone receptor status of individual foci in multifocal invasive ductal breast cancer Acta Oncol 46 2007 204 207
27. Y. Choi, E.J. Kim, and H. Seol et al. The hormone receptor, human epidermal growth factor receptor 2, and molecular subtype status of individual tumor foci in multifocal/multicentric invasive ductal carcinoma of breast Hum Pathol 43 2012 48 55
28. M. Pekmezci, A. Szpaderska, C. Osipo, and C. Ersahin Evaluation of biomarkers in multifocal/multicentric invasive breast carcinomas Int J Surg Pathol 21 2013 126 132
29. F. Buggi, S. Folli, and A. Curcio et al. Multicentric/multifocal breast cancer with a single histotype: is the biological characterization of all individual foci justified? Ann Oncol 23 2012 2042 2046